Back

Primary Results of the VHD-W (Valvular Heart Disease in Women) Study

31 August 2026 (14:15 - 14:30)
Organised by: Logo
Congress Presentation Part of: Valvular heart disease: lessons from real-world practice Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Julia Grapsa

Brigham and Women's Hospital, Heart and Vascular Center, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
Medium-term outcomes following contemporary transcatheter aortic valve implantation in England: insights from national registry linkage
Professor R. Kharbanda (Oxford, GB)
Presentation thumbnail
Isolated Tricuspid Valve Replacement at 20-Year Follow-up. Insight from the largest multicenter international registry. DURABLE Tricuspid
Doctor E. Zancanaro (Mainz, DE)
Presentation thumbnail
How Much Tricuspid Regurgitation Reduction Is Enough? Residual TR and Long-Term Outcomes After T-TEER in the Randomized TRI-FR Extension
Professor E. Donal (Rennes, FR)

Access the full session

Session thumbnail
Valvular heart disease: lessons from real-world practice

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Session
How to manage valvular heart disease in heart failure
19 May 2025
thumbnail
Congress Presentation
Sex-related differences in cardiac damage associated with severe primary mitral regurgitation: impact on surgical outcomes
13 December 2024
thumbnail
Webinar
Heart disease in women: enhancing outcomes through improved care
21 November 2025
thumbnail
Webinar
The EAPCI Journal Club - RHEIA trial: transcatheter vs. surgical aortic valve replacement in women with severe aortic stenosis
30 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources